chrX-111251613-C-G

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_014289.4(CAPN6):​c.829G>C​(p.Val277Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0591 in 1,207,785 control chromosomes in the GnomAD database, including 9,167 homozygotes. There are 20,632 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in UniProt.

Frequency

Genomes: 𝑓 0.20 ( 4485 hom., 5876 hem., cov: 22)
Exomes 𝑓: 0.045 ( 4682 hom. 14756 hem. )

Consequence

CAPN6
NM_014289.4 missense

Scores

1
15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 2.52
Variant links:
Genes affected
CAPN6 (HGNC:1483): (calpain 6) Calpains are ubiquitous, well-conserved family of calcium-dependent, cysteine proteases. The calpain proteins are heterodimers consisting of an invariant small subunit and variable large subunits. The large subunit possesses a cysteine protease domain, and both subunits possess calcium-binding domains. Calpains have been implicated in neurodegenerative processes, as their activation can be triggered by calcium influx and oxidative stress. The protein encoded by this gene is highly expressed in the placenta. Its C-terminal region lacks any homology to the calmodulin-like domain of other calpains. The protein lacks critical active site residues and thus is suggested to be proteolytically inactive. The protein may play a role in tumor formation by inhibiting apoptosis and promoting angiogenesis. [provided by RefSeq, Nov 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=1.9559777E-5).
BP6
Variant X-111251613-C-G is Benign according to our data. Variant chrX-111251613-C-G is described in ClinVar as [Benign]. Clinvar id is 1288617.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.611 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CAPN6NM_014289.4 linkc.829G>C p.Val277Leu missense_variant Exon 6 of 13 ENST00000324068.2 NP_055104.2 Q9Y6Q1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CAPN6ENST00000324068.2 linkc.829G>C p.Val277Leu missense_variant Exon 6 of 13 1 NM_014289.4 ENSP00000317214.1 Q9Y6Q1

Frequencies

GnomAD3 genomes
AF:
0.196
AC:
21791
AN:
111161
Hom.:
4480
Cov.:
22
AF XY:
0.175
AC XY:
5832
AN XY:
33387
show subpopulations
Gnomad AFR
AF:
0.618
Gnomad AMI
AF:
0.00581
Gnomad AMR
AF:
0.0983
Gnomad ASJ
AF:
0.0194
Gnomad EAS
AF:
0.00140
Gnomad SAS
AF:
0.0110
Gnomad FIN
AF:
0.0123
Gnomad MID
AF:
0.125
Gnomad NFE
AF:
0.0310
Gnomad OTH
AF:
0.169
GnomAD3 exomes
AF:
0.0715
AC:
13119
AN:
183409
Hom.:
2096
AF XY:
0.0542
AC XY:
3677
AN XY:
67861
show subpopulations
Gnomad AFR exome
AF:
0.630
Gnomad AMR exome
AF:
0.0525
Gnomad ASJ exome
AF:
0.0248
Gnomad EAS exome
AF:
0.000721
Gnomad SAS exome
AF:
0.00917
Gnomad FIN exome
AF:
0.0151
Gnomad NFE exome
AF:
0.0306
Gnomad OTH exome
AF:
0.0594
GnomAD4 exome
AF:
0.0452
AC:
49518
AN:
1096571
Hom.:
4682
Cov.:
30
AF XY:
0.0408
AC XY:
14756
AN XY:
362007
show subpopulations
Gnomad4 AFR exome
AF:
0.638
Gnomad4 AMR exome
AF:
0.0594
Gnomad4 ASJ exome
AF:
0.0232
Gnomad4 EAS exome
AF:
0.000497
Gnomad4 SAS exome
AF:
0.0108
Gnomad4 FIN exome
AF:
0.0151
Gnomad4 NFE exome
AF:
0.0299
Gnomad4 OTH exome
AF:
0.0738
GnomAD4 genome
AF:
0.196
AC:
21843
AN:
111214
Hom.:
4485
Cov.:
22
AF XY:
0.176
AC XY:
5876
AN XY:
33450
show subpopulations
Gnomad4 AFR
AF:
0.618
Gnomad4 AMR
AF:
0.0981
Gnomad4 ASJ
AF:
0.0194
Gnomad4 EAS
AF:
0.00141
Gnomad4 SAS
AF:
0.0102
Gnomad4 FIN
AF:
0.0123
Gnomad4 NFE
AF:
0.0310
Gnomad4 OTH
AF:
0.166
Alfa
AF:
0.0565
Hom.:
1620
Bravo
AF:
0.225
TwinsUK
AF:
0.0286
AC:
106
ALSPAC
AF:
0.0294
AC:
85
ESP6500AA
AF:
0.611
AC:
2345
ESP6500EA
AF:
0.0314
AC:
211
ExAC
AF:
0.0772
AC:
9379
EpiCase
AF:
0.0317
EpiControl
AF:
0.0327

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Jun 09, 2021
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.86
T
BayesDel_noAF
Benign
-0.86
CADD
Benign
11
DANN
Benign
0.51
DEOGEN2
Benign
0.038
T
FATHMM_MKL
Benign
0.32
N
LIST_S2
Benign
0.10
T
MetaRNN
Benign
0.000020
T
MetaSVM
Benign
-0.94
T
MutationAssessor
Benign
-0.78
N
PrimateAI
Uncertain
0.54
T
PROVEAN
Benign
1.1
N
REVEL
Benign
0.069
Sift
Benign
1.0
T
Sift4G
Benign
1.0
T
Polyphen
0.0
B
Vest4
0.010
MutPred
0.24
Loss of MoRF binding (P = 0.1034);
MPC
0.44
ClinPred
0.0045
T
GERP RS
5.3
Varity_R
0.068
gMVP
0.40

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs12013711; hg19: chrX-110494841; COSMIC: COSV60695463; API